Nuplazid Drug Interactions: 48 Major, 458 Moderate
Nuplazid (Pimavanserin Tartrate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Nuplazid. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Pimavanserin can be increased when combined with Abatacept.
Level 1 evidence
Abemaciclib
The metabolism of Abemaciclib can be decreased when combined with Pimavanserin.
Level 2 evidence
Acalabrutinib
The metabolism of Acalabrutinib can be decreased when combined with Pimavanserin.
Level 2 evidence
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Pimavanserin.
Level 1 evidence
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Pimavanserin.
Level 2 evidence
Acetaminophen
The metabolism of Pimavanserin can be increased when combined with Acetaminophen.
Level 2 evidence
Acetazolamide
The metabolism of Pimavanserin can be decreased when combined with Acetazolamide.
Level 2 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pimavanserin.
Level 1 evidence
Adagrasib
The risk or severity of QTc prolongation can be increased when Adagrasib is combined with Pimavanserin.
Level 1 evidence
Adalimumab
The metabolism of Pimavanserin can be increased when combined with Adalimumab.
Level 1 evidence
Adenosine
The risk or severity of QTc prolongation can be increased when Adenosine is combined with Pimavanserin.
Level 1 evidence
Albendazole
The metabolism of Pimavanserin can be decreased when combined with Albendazole.
Level 2 evidence
Enter your NPI to unlock 6 major interactions for Nuplazid
Nuplazid (Pimavanserin Tartrate) has 551 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Nuplazid (Pimavanserin Tartrate) has 48 major, 458 moderate, and 45 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Nuplazid. Always confirm against the full prescribing information.